Robin Kimiko Avery MD
Transplant/Immunocompromised States
Professor of Medicine, Division of Infectious Disease, Johns Hopkins University
Join to View Full Profile
10751 Falls RoadFalls Concourse Ste 412Lutherville, MD 21093
Phone+1 410-583-2900
Fax+1 410-583-2654
Dr. Avery is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I have over 25 years of experience in the field of Transplant/Oncology Infectious Disease (Cleveland Clinic 1993-2012; Johns Hopkins 2012 - present), and have served as a past Chair of the Infectious Diseases Community of Practice of the American Society of Transplantation as well as founding Section Head for Transplant ID at Cleveland Clinic. My clinical research interests include transplant-related viral infections (CMV, BKV, chronic norovirus), novel antivirals, post-transplant hypogammaglobulinemia, strategies for safer living after transplant, and patient education.
Education & Training
Mass General Brigham/Massachusetts General Hospital/Brigham and Women's HospitalFellowship, Infectious Disease, 1989 - 1993- Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 1986 - 1988
- Mass General Brigham/Massachusetts General HospitalInternship, Internal Medicine, 1985 - 1986
Harvard Medical SchoolClass of 1985
Certifications & Licensure
MD State Medical License 2012 - 2026
OH State Medical License 1993 - 2013
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Best Consulting Physician Johns Hopkins Hospital, 2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2011, 2015-2017
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2011, 2015-2017
Clinical Trials
- The Johns Hopkins Transplant Infectious Diseases Prospective Cohort Study Start of enrollment: 2011 Jun 01
- Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation Start of enrollment: 2015 Jun 01
- A Study of Maribavir Compared to Valganciclovir to Treat Cytomegalovirus Infections in People Who Have Received Stem Cell Transplants Start of enrollment: 2017 Apr 14
Publications & Presentations
PubMed
- Demographics and Geographic Accessibility of Invasive Fungal Infection Clinical Trial Sites.Lucy X Li, Jiashu Xue, Olivia S Kates, Robin K Avery, Sean X Zhang
JAMA Network Open. 2026-06-01 - A phase 2 multicenter, prospective, randomized, double-blind study to assess the clinical and antiviral efficacy and safety of nitazoxanide for the treatment of norovi...Catherine-Audrey Boutin, Michelle Callegari, Diana Florescu, Minh-Hong Nguyen, Daniel Kaul
American Journal of Transplantation. 2026-05-22 - 2 citationsOptimizing IVIg in Xenotransplantation: A Call to Action.Robin K Avery, Olivia S Kates, Kapil K Saharia, Brian K Lindner, John W Baddley
Transplantation. 2026-05-01
Journal Articles
- Definitions of Resistant and Refractory Cytomegalovirus Infection and Disease in Transplant Recipients for Use in Clinical TrialsRoy F Chemaly, Kathleen M Mullane, Robin Avery, Raymund R Razonable, Clinical Infectious Diseases
- Severe chronic norovirus diarrheal disease in transplant recipients: Clinical features of an under-recognized syndromeAvery RK, Lonze BE, Kraus ES, Marr KA, Montgomery RA, Transplant Infectious Disease, 2017
Lectures
- Cytomegalovirus Reactivation in Haploidentical Blood or Marrow Transplant (BMT) Using Post-Transplant Cyclophosphamide (PTCy) Is Associated with Higher Non-Relapse-Rel...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Severe Infections in Liver and Lung Transplant RecipientsInternational Immunocompromised Host Society Meeting, Athens, Greece - 6/19/2018
- CMV Resistance and Challenging Infections: Time to Get CreativeInternational Society for Heart and Lung Transplantation, Nice, France - 4/12/2018
Press Mentions
Kidney Transplant Outcomes Appear No Worse for Undocumented ImmigrantsAugust 9th, 2021- Management of COVID-19 in Transplant Recipients Evolved During PandemicJuly 15th, 2021
- The High-Risk Group for Whom Covid-19 Vaccines May Not Work EffectivelyApril 20th, 2021
Committees
- Member/Co-Author, ISHLT Fungal Infections Guidelines Committee 2013 - 2014
- Member/Co-Author, AST Committee on the Hepatitis B Core Positive Donor 2013 - 2014
- Member/Co-Author, IDSA Guidelines Committee for Immunization of the Immunocompromised Host 2008 - 2013
- Chair, American Society of Transplantation Infectious Disease Community of Practice 2002 - 2004
Professional Memberships
- American Society of TransplantationFellow
- Fellow
- International Society for Heart and Lung Transplantation (ISHLT)Member
- Immunocompromised Host SocietyCouncil Member
- Member
Industry Relationships
- Unpaid Consultant, ShireUnpaid consultant to studies regarding CMV and the investigational drug maribavir.Disclosure: No financial remuneration for this activity.2016 - Present
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/robin-avery
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
